| Value | ₹47.99 Cr |
|---|
NSE filing, NSE: FWSTC. Summary written from the filing by ALFA Finder's alert engine.
Flywings Simulator Training Centre Ltd: key numbers
- Share price
- ₹279.10
- Market cap
- ₹284.0 Cr
- Revenue (annual)
- ₹24.51 Cr
- Net profit (annual)
- ₹11.64 Cr
- P/E (TTM)
- 24.4×Sector 33.4×
- Promoter holding
- 59.87%
- FII holding
- 1.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Flywings Simulator Training Centre Ltd
All →Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Flywings Simulator Training Centre Capacity Expansion
Flywings Simulator Training Centre announced the upcoming launch of its new flying school at Dholera International Airport, Gujarat, as part of its aviation training expansion.
Flywings Simulator Training Centre Other Announcement
Flywings Simulator Training Centre corrected an inadvertent error in its FY26 earnings call transcript. Captain Sanjay Mandavia's designation was wrongly stated as CEO; no management change exists.
Flywings Simulator Training Centre Annual General Meeting
Flywings Simulator Training Centre Limited has issued a notice for an Extra-Ordinary General Meeting (EGM) scheduled for November 05, 2026, to be held via video conferencing.
Flywings Simulator Training Centre Board Meeting Outcome
Flywings Simulator Training Centre Ltd's board approved altering its Memorandum of Association to add transportation and mobility objects. An EGM is convened for 5th November 2026.
Flywings Simulator Training Centre Board Meeting Date
Flywings Simulator Training Centre Ltd has cancelled its board meeting originally scheduled for October 8, 2026. The company will announce a revised meeting date later.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr